Cargando…

SARS-COV-2 antibodies after booster vaccination. Identification of subgroups with poor response

OBJECTIVE: To determine which patients within the high-risk group are most likely to have insufficient post-vaccination immunity. METHODS: Determination of IgG titers against SARS-CoV-2 after the booster dose. Vaccine response was categorized as negative (IgG titers < 34 BAU/ml), indeterminate (t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayuso García, B., Romay Lema, E., Pérez López, A., Suárez Piñera, A., Pereiro Belay, M.C., Gude González, M.J., Rabuñal Rey, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Espana 2023
Materias:	Brief Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154241/ https://www.ncbi.nlm.nih.gov/pubmed/37146747 http://dx.doi.org/10.1016/j.rceng.2023.04.008

Ejemplares similares

Anticuerpos contra el SARS-CoV-2 tras la dosis de vacuna de recuerdo. Identificación de subgrupos con respuesta insuficiente
por: Ayuso García, B., et al.
Publicado: (2023)

Health Perception among Female COVID-19 Patients. Comment on Fernández-de-las-Peñas et al. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022, 11, 413
por: Ayuso García, Blanca, et al.
Publicado: (2022)

Useful tools in post-COVID syndrome evaluation
por: Ayuso García, Blanca, et al.
Publicado: (2022)

Useful tools in post-COVID syndrome evaluation
por: Ayuso García, Blanca, et al.
Publicado: (2022)

Calidad de vida relacionada con la salud en pacientes recuperados de COVID-19
por: Ayuso García, B., et al.
Publicado: (2022)

High Levels of Anti-SARS-CoV-2 Receptor-Binding Domain (RBD) Antibodies One Year Post Booster Vaccinations among Hospital Workers in Indonesia: Was the Second Booster Needed?
por: Muslimah, Amila Hanifan, et al.
Publicado: (2023)

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination
por: Pérez-Then, Eddy, et al.
Publicado: (2022)

Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases
por: Chauhan, Mahak, et al.
Publicado: (2022)

Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers
por: Kwon, Seok Ryun, et al.
Publicado: (2022)

Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?
por: Stellini, Roberto, et al.
Publicado: (2022)

Booster BNT162b2 COVID-19 Vaccination Increases Neutralizing Antibody Titers Against the SARS-CoV-2 Omicron Variant in Both Young and Elderly Adults
por: Um, Jihye, et al.
Publicado: (2022)

Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial
por: George, Daniel J., et al.
Publicado: (2019)

Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System Demyelination
por: Ayroza Galvão Ribeiro Gomes, Ana Beatriz, et al.
Publicado: (2023)

Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
por: Sitaras, Ioannis, et al.
Publicado: (2022)

Antibody response to SARS-CoV-2 booster vaccines
por: Loving, Hanna S., et al.
Publicado: (2022)

Humoral response to heterologous prime‐booster vaccination in heart transplant recipients aged 18–70 years primed with a viral vector SARS‐CoV‐2 vaccine
por: Tanner, Richard, et al.
Publicado: (2022)

COVID-19 Booster Vaccination Bellwethers: Factors Predictive of Older Adults’ Adoption of the Second Booster COVID-19 Vaccine in Israel: A Longitudinal Study
por: Ben-David, Boaz M., et al.
Publicado: (2023)

SARS-CoV-2 antibody seroconversion in care home
por: Shang, Joan, et al.
Publicado: (2020)

SARS-CoV-2-specific T cells without antibodies
por: Bozkus, Cansu Cimen
Publicado: (2020)

Antibody responses to SARS-CoV-2 short-lived
por: Vabret, Nicolas
Publicado: (2020)

Human antibodies can neutralize SARS-CoV-2
por: Catalan-Dibene, Jovani
Publicado: (2020)

SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy
por: Vicenti, Ilaria, et al.
Publicado: (2023)

Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant
por: Del Mastro, Andrea, et al.
Publicado: (2023)

Factores asociados al ingreso hospitalario en un protocolo asistencial en COVID-19
por: Golpe, Rafael, et al.
Publicado: (2020)

Factors Associated to Hospital Admission in a Care Protocol in COVID-19()
por: Golpe, Rafael, et al.
Publicado: (2020)

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
por: Gruell, Henning, et al.
Publicado: (2022)

Oral booster vaccine antigen—Expression of full‐length native SARS‐CoV‐2 spike protein in lettuce chloroplasts
por: Singh, Rahul, et al.
Publicado: (2023)

Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
por: O'Brien, Thomas R., et al.
Publicado: (2014)

COVID-19 Booster Vaccination in the U.S. Military, August 2021–January 2022
por: Winkler, Erin L., et al.
Publicado: (2023)

Antibody response to SARS-CoV-2 — sustained after all?
por: Compeer, Ewoud B., et al.
Publicado: (2020)

Population subgroup differences in the use of a COVID-19 chatbot
por: Schubel, Laura C., et al.
Publicado: (2021)

Characteristics of Postvaccination Coronavirus Disease 2019 Hospitalizations Prior to Booster Vaccines
por: Moffa, Matthew A, et al.
Publicado: (2022)

COVID-19 Booster Vaccine Equity for Patients With Cancer
por: Prasad, Rahul N., et al.
Publicado: (2022)

Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies
por: Rick, Anne-Marie, et al.
Publicado: (2023)

Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors
por: Quee, F. A., et al.
Publicado: (2023)

SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers
por: Santi, Theresia, et al.
Publicado: (2022)

Multiple sclerosis treatment blunts SARS-CoV-2 antibody response
por: Lemprière, Sarah
Publicado: (2021)

SARS-CoV-2 variant evades antibodies whilst maintaining fitness
por: Flemming, Alexandra
Publicado: (2021)

Evaluation of the Effectiveness of BNT162b2 Primary Vaccination and Booster Dose to SARS-CoV-2 in Eliciting Stable Mucosal Immunity
por: Lambiase, Alessandro, et al.
Publicado: (2022)

Effectiveness of Humidification with Heat and Moisture Exchanger-booster in Tracheostomized Patients
por: Gonzalez, Isabel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4fpa43nlm9rb639a5up5fpvbkh